Кримський Державний Медичний Університет Ім. С.І. Георгієвського
Крымский Государственный Медицинский Университет Им. С.И. Георгиевского
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кримський Державний Медичний Університет Ім. С.І. Георгієвського, Крымский Государственный Медицинский Университет Им. С.И. ГеоргиевскогоfiledCriticalКримський Державний Медичний Університет Ім. С.І. Георгієвського
Priority to UA2001032030ApriorityCriticalpatent/UA42527A/en
Publication of UA42527ApublicationCriticalpatent/UA42527A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The method for treating the chronic hepatitis C comprises the intramuscular injections of recombinant alpha-2b interferon (the domestically produced interferon preparation named Laferon) at a dose 3 millions IU thrice a week. The interval between the courses of the treatment is up to 6 weeks. The biologic preparations produced by Heel company (Engistol, Hepel, Ecchinacea compositum) are used between the courses of interferon. The overall duration of the treatment is 10-12 months.
UA2001032030A2001-03-272001-03-27Method for treating chronic hepatitis c
UA42527A
(en)